Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Integrilin and Ilomedin in Combination in Comparison to Standard Treatment in Severe Pneumonia Patients With Severe Sepsis

This study has been terminated.
(Difficulty recruiting patients, company closed down)
Anders Perner
Rigshospitalet, Denmark
Information provided by (Responsible Party):
Thrombologic ApS Identifier:
First received: January 30, 2012
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)